NCT06415097View on ClinicalTrials.gov

Benefits of Smart Pens in Type 1 Diabetes

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Type 1 Diabetes

Interventions

DEVICE

Insulin Smart Pen

Retrospective analysis of electronic health records for individuals with type 1 diabetes receiving multiple daily doses of insulin, combined with glucose monitoring devices and who have used or are currently using insulin smart pens.

Trial Locations (1)

46010

INCLIVA, Valencia

All Listed Sponsors

lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER

NCT06415097 - Benefits of Smart Pens in Type 1 Diabetes | Biotech Hunter | Biotech Hunter